HK1050318A1 - 多劑量紅細胞生成素製劑 - Google Patents

多劑量紅細胞生成素製劑

Info

Publication number
HK1050318A1
HK1050318A1 HK03102133.1A HK03102133A HK1050318A1 HK 1050318 A1 HK1050318 A1 HK 1050318A1 HK 03102133 A HK03102133 A HK 03102133A HK 1050318 A1 HK1050318 A1 HK 1050318A1
Authority
HK
Hong Kong
Prior art keywords
formulations
dose erythropoietin
erythropoietin formulations
dose
phenoxyethanol
Prior art date
Application number
HK03102133.1A
Other languages
English (en)
Inventor
A‧加耶德
Original Assignee
阿溫蒂斯藥物公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿溫蒂斯藥物公司 filed Critical 阿溫蒂斯藥物公司
Publication of HK1050318A1 publication Critical patent/HK1050318A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK03102133.1A 1999-07-22 2003-03-24 多劑量紅細胞生成素製劑 HK1050318A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22
PCT/US2000/040446 WO2001007075A2 (en) 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations

Publications (1)

Publication Number Publication Date
HK1050318A1 true HK1050318A1 (zh) 2003-06-20

Family

ID=22732468

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102133.1A HK1050318A1 (zh) 1999-07-22 2003-03-24 多劑量紅細胞生成素製劑

Country Status (25)

Country Link
US (1) US7432360B2 (zh)
EP (1) EP1200115B9 (zh)
JP (1) JP2003517462A (zh)
KR (1) KR100693263B1 (zh)
CN (2) CN1371284A (zh)
AT (1) ATE304863T1 (zh)
AU (1) AU777397B2 (zh)
BR (1) BR0012667A (zh)
CA (1) CA2378945C (zh)
CZ (1) CZ302750B6 (zh)
DE (1) DE60022759T2 (zh)
DK (1) DK1200115T3 (zh)
EA (1) EA006220B1 (zh)
EE (1) EE200200037A (zh)
ES (1) ES2248110T3 (zh)
HK (1) HK1050318A1 (zh)
HR (1) HRP20020159B1 (zh)
HU (1) HUP0202246A3 (zh)
IL (2) IL147755A0 (zh)
NO (1) NO20020303L (zh)
NZ (1) NZ516735A (zh)
PL (1) PL202945B1 (zh)
RS (1) RS50355B (zh)
WO (1) WO2001007075A2 (zh)
ZA (1) ZA200200742B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL353026A1 (en) 1999-07-22 2003-10-06 Aventis Pharmaceuticals, Inc. Preserved pharmaceutical formulations
ATE291436T2 (de) 2000-05-15 2005-04-15 Hoffmann La Roche Flüssige arzneizubereitung enthaltend ein erythropoietin derivat
EA010889B1 (ru) * 2004-03-26 2008-12-30 Янссен Фармацевтика Н.В. Комбинированная схема дозирования эритропоэтина
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
BRPI0606784B1 (pt) * 2005-02-03 2018-07-31 Clariant Produkte (Deutschland) Gmbh Conservantes
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
CN108135841B (zh) * 2015-10-22 2024-03-05 艾尔图制药公司 Il-2的药物组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co DRUG
JP2000504319A (ja) * 1996-01-19 2000-04-11 イーライ・リリー・アンド・カンパニー 肥満症タンパク質製剤
EP0958831A4 (en) * 1996-09-13 2004-04-07 Advanced Medicine Res Inst OPHTHALMIC COMPOSITIONS OF NEUROTROPHIC FACTORS, REMEDIES FOR FUNCTIONAL OPTIC NERVE DISORDERS AND METHOD FOR TREATING SUCH DISORDERS
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
DE60022759T2 (de) 2006-06-22
PL353569A1 (en) 2003-12-01
DE60022759D1 (de) 2006-02-02
HRP20020159B1 (en) 2007-08-31
JP2003517462A (ja) 2003-05-27
DK1200115T3 (da) 2006-01-16
NZ516735A (en) 2004-01-30
NO20020303L (no) 2002-03-21
KR20020011143A (ko) 2002-02-07
IL147755A (en) 2009-11-18
HUP0202246A2 (en) 2002-10-28
BR0012667A (pt) 2002-07-02
HUP0202246A3 (en) 2010-01-28
RS50355B (sr) 2009-11-10
EP1200115B9 (en) 2006-01-18
CN101091792A (zh) 2007-12-26
AU7137400A (en) 2001-02-13
EP1200115B1 (en) 2005-09-21
CN1371284A (zh) 2002-09-25
ES2248110T3 (es) 2006-03-16
US7432360B2 (en) 2008-10-07
CZ302750B6 (cs) 2011-10-19
EP1200115A2 (en) 2002-05-02
US20050267033A1 (en) 2005-12-01
CA2378945C (en) 2010-02-23
HRP20020159A2 (en) 2003-06-30
CZ2002264A3 (cs) 2002-06-12
CA2378945A1 (en) 2001-02-01
EA200200073A1 (ru) 2002-08-29
KR100693263B1 (ko) 2007-03-13
ATE304863T1 (de) 2005-10-15
WO2001007075A2 (en) 2001-02-01
NO20020303D0 (no) 2002-01-21
EA006220B1 (ru) 2005-10-27
ZA200200742B (en) 2003-06-25
YU4702A (sh) 2005-06-10
WO2001007075A3 (en) 2001-10-04
PL202945B1 (pl) 2009-08-31
IL147755A0 (en) 2002-08-14
AU777397B2 (en) 2004-10-14
EE200200037A (et) 2003-04-15

Similar Documents

Publication Publication Date Title
DE69730202D1 (de) Azidfreie, gaserzeugende zusammensetzungen
ZA99780B (en) Styling shampoo compositions.
AU2002215935A1 (en) Novel use of short-chained carboxylic acids
FR2770110B1 (fr) Boitier, du type boitier de maquillage
BG101540A (en) Interferon conjugates
ZA200005478B (en) Shampoo compositions.
AU3950099A (en) Hair styling compositions
IL149459A0 (en) Recombinant gelatins
ZA979284B (en) Styling shampoo compositions with improved styling polymer deposition.
GB9903216D0 (en) Preservative compounds,compositions and methods of making and using the same
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
EP1083903A4 (en) INDENOPYRROLOCARBAZOLES BRIDGES
ZA995770B (en) Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibres, dyeing compositions, and methods of dyeing.
AU3818300A (en) Treating hair by targeting enzymes
CA2392620A1 (en) Use of melatonin for the treatment of androgenetic and diffuse alopecia
ZA200200742B (en) Multi-dose erythropoietin formulations.
DE69616074D1 (de) Ara-c derivate
AU3164400A (en) Low voc hair spray compositions having enhanced styling benefits
EP0983243A4 (en) NOVEL QUINOLINE- AND NAPHTHALENECARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING CALPAIN
NO990498D0 (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
AU1252797A (en) Application of coatings to seeds, etc.
AU6832498A (en) Substituted benzyl oximino compounds
AP9901529A0 (en) Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them.
WO1999061598A3 (en) Lentiviral vector compositions and methods of use
WO2001097771A3 (de) Zubereitungen enthaltend einen extrakt der pflanze pistia stratiotes